Abdul Mannan on Finding the Right Balance – The Blood Thinner Dilemma
Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, posted on LinkedIn:
”Stopping blood thinners after a clot is tricky. You might stop too soon and get another clot. Or you might stay on them too long and bleed.
We used to rely on fancy scores and tests. Now guidelines say don’t bother with most of them. Just talk to your patient.
If the clot had no clear cause, you probably need longer treatment. If it happened after surgery, you can stop sooner.
Cancer patients stay on treatment whilst the cancer is active. Simple as that.
Three months treats the clot. After that, you’re preventing the next one. That’s when the hard choices start.
Some tools help predict risk. But ASH says use them only if they’ll actually change your plan. Otherwise, skip them.
Lower doses work for prevention after the first months. Balance is everything.”
Stay updated with Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?